🇺🇸 FDA
Patent

US 10196383

Substituted quinazoline compounds and preparation and uses thereof

granted A61KA61K31/551A61K45/06

Quick answer

US patent 10196383 (Substituted quinazoline compounds and preparation and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/551, A61K45/06, A61P, A61P25/00